27feb(feb 27)7:00 am28(feb 28)1:00 pmUpdates on Advanced Breast Cancer: Local Management and Other New Perspectives

Event Details

Friday, Feb. 27 – Saturday, Feb. 28, 2026
Marriott Medical Center Hotel
Houston, Houston, TX

This activity emphasizes the integration of novel therapies and diagnostic tools into clinical practice, including liquid biopsy, ctDNA, and MRD monitoring for inflammatory breast cancer (IBC). It also explores DDR-targeted strategies, CAR-T therapy limitations, and the role of T-cell receptor and vaccine-based immunotherapies. Experts will highlight interdisciplinary collaboration, including the roles of nurse navigators, advanced practice providers, and social workers.

Objectives

Evaluate and apply DDR-targeted and CAR-T strategies in the treatment of advanced breast cancer.
Incorporate ctDNA and MRD monitoring into clinical decision-making for advanced breast cancer patients.
Identify and manage emerging toxicities associated with novel therapies in advanced breast cancercare.
Integrate immunotherapy and vaccine-based approaches into treatment plans for oligometastatic and inflammatory breast cancer.
Enhance interdisciplinary collaboration, including the roles of social workers, advanced practice providers, and nurse navigators to improve patient outcomes.

Credits		Target Audience
9.25 AMA PRA Category 1 Credits^TM 9.25 Non-Physician Attendance 9.25 ANCC – Nursing Contact Hours 9.25 ACPE Contact Hours ABIM MOC Part 2 9.25 AAPA Category 1 CME		Nurses Physicians Physicians Assistants Pharmacist Social Workers Students or Trainees